Hospira a takeover target

Quote

Anonymous

Guest
Would anybody really want to aquire this train wreak? Any life this company had was sucked out a couple years ago and put in to corporate officers pockets.

Employees have no respect for the current leadership. It's everyone for themselves. Get what you can out of this company. That's the Begley way. Management tells you one thing but they mean something totally different. Propaganda plane and simple. They preach integrity but to them if your not breaking the law it's fair game. Regardless if it's unethical. Like lots of half truths. White lies. Deceptions.

All the manufacturing facilities were crippled with Project Lean and Fuel. Employee morale and trust is non-existant. You could save some money by not eating for a while but eventually it will kill you. That's what was done to these facilities.

Here is a good read for the kind of money these crooks are getting for trashing Hospira.

Page 40 and 41 describes compensation if their employment were severed with the company.

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9Mzc3ODl8Q2hpbGRJRD0tMXxUeXBlPTM=&t=1


2.99 Times Value of Accelerated Performance
Salary and Employee Vesting of Shares or Excise Taxes
Bonus 2009 Benefits Stock Restricted and Related
Officer Payment(1) Incentive(2) and Services Pension(3) Options(4) Shares(5) Payments(6) Total
Christopher B. Begley . $6,279,000 $1,050,000 $132,788 $154,719 $8,438,044 $7,677,081 $5,430,417 $29,162,049
Terrence C. Kearney . . 3,363,750 500,000 132,820 65,816 4,764,961 3,504,975 2,360,319 14,692,641
Sumant Ramachandra . 2,616,250 400,000 131,070 31,211 4,057,477 4,063,425 3,284,793 14,584,226
Ron Squarer . . . . . . . 1,292,000 266,000 86,931 — 2,531,173 2,043,825 1,436,019 7,655,948
Thomas E. Werner . . . 2,532,404 401,958 130,980 — 3,069,436 2,445,450 2,641,928 11,222,156
 






Anonymous said:
Would anybody really want to aquire this train wreak? Any life this company had was sucked out a couple years ago and put in to corporate officers pockets.

Employees have no respect for the current leadership. It's everyone for themselves. Get what you can out of this company. That's the Begley way. Management tells you one thing but they mean something totally different. Propaganda plane and simple. They preach integrity but to them if your not breaking the law it's fair game. Regardless if it's unethical. Like lots of half truths. White lies. Deceptions.

All the manufacturing facilities were crippled with Project Lean and Fuel. Employee morale and trust is non-existant. You could save some money by not eating for a while but eventually it will kill you. That's what was done to these facilities.

Here is a good read for the kind of money these crooks are getting for trashing Hospira.

Page 40 and 41 describes compensation if their employment were severed with the company.

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9Mzc3ODl8Q2hpbGRJRD0tMXxUeXBlPTM=&t=1


2.99 Times Value of Accelerated Performance
Salary and Employee Vesting of Shares or Excise Taxes
Bonus 2009 Benefits Stock Restricted and Related
Officer Payment(1) Incentive(2) and Services Pension(3) Options(4) Shares(5) Payments(6) Total
Christopher B. Begley . $6,279,000 $1,050,000 $132,788 $154,719 $8,438,044 $7,677,081 $5,430,417 $29,162,049
Terrence C. Kearney . . 3,363,750 500,000 132,820 65,816 4,764,961 3,504,975 2,360,319 14,692,641
Sumant Ramachandra . 2,616,250 400,000 131,070 31,211 4,057,477 4,063,425 3,284,793 14,584,226
Ron Squarer . . . . . . . 1,292,000 266,000 86,931 — 2,531,173 2,043,825 1,436,019 7,655,948
Thomas E. Werner . . . 2,532,404 401,958 130,980 — 3,069,436 2,445,450 2,641,928 11,222,156
Click to expand...

it is amazing how the officers pay does not reflect the dire straits that they said this company is in.
 






Your looking at past performance and not potential value. "Entities", like Chris Begley's, friend, Mitt Romney's Bain Capital, look at value or in this case hidden value within Hospira. Bain or KKR (Private Equity) would look at the potential future value of Hospira's: 1. injectable business and it's impact on the supply of that product (HSP may have future pricing leverage), 2. oncology franchise/manufacturing, reason for acquiring Mayne Pharma (oncology mfg), 3. cash/cash flow, HSP has a great cash position from retaining earnings and not retiring debt. Debt is no problem too many large Rx companies. 4. Pharma Diversity, many properitary manufacturers don't have good drug pipelines, they look to the JNJ model for diversification. Miles White traded out HSP for Humira....going from a complex franchise of over 2,500 products made "worldwide" to one pill with enormous potential years ago. While, unloading an enormous obligation called retiree healthcare and pension within Abbott HPD. Now the pendelum will swing back. As another post noted, Abbott still has first rights to re-acquire HSP.
The question is...was that done legally?
Big Pharma/Bio-tech or Private Equity will make a move once that question is answered. Sell off the device business and streamline within a new structure.

New Capitalism of making money without a new "widget".




Anonymous said:
Would anybody really want to aquire this train wreak? Any life this company had was sucked out a couple years ago and put in to corporate officers pockets.

Employees have no respect for the current leadership. It's everyone for themselves. Get what you can out of this company. That's the Begley way. Management tells you one thing but they mean something totally different. Propaganda plane and simple. They preach integrity but to them if your not breaking the law it's fair game. Regardless if it's unethical. Like lots of half truths. White lies. Deceptions.

All the manufacturing facilities were crippled with Project Lean and Fuel. Employee morale and trust is non-existant. You could save some money by not eating for a while but eventually it will kill you. That's what was done to these facilities.

Here is a good read for the kind of money these crooks are getting for trashing Hospira.

Page 40 and 41 describes compensation if their employment were severed with the company.

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9Mzc3ODl8Q2hpbGRJRD0tMXxUeXBlPTM=&t=1


2.99 Times Value of Accelerated Performance
Salary and Employee Vesting of Shares or Excise Taxes
Bonus 2009 Benefits Stock Restricted and Related
Officer Payment(1) Incentive(2) and Services Pension(3) Options(4) Shares(5) Payments(6) Total
Christopher B. Begley . $6,279,000 $1,050,000 $132,788 $154,719 $8,438,044 $7,677,081 $5,430,417 $29,162,049
Terrence C. Kearney . . 3,363,750 500,000 132,820 65,816 4,764,961 3,504,975 2,360,319 14,692,641
Sumant Ramachandra . 2,616,250 400,000 131,070 31,211 4,057,477 4,063,425 3,284,793 14,584,226
Ron Squarer . . . . . . . 1,292,000 266,000 86,931 — 2,531,173 2,043,825 1,436,019 7,655,948
Thomas E. Werner . . . 2,532,404 401,958 130,980 — 3,069,436 2,445,450 2,641,928 11,222,156
Click to expand...
 






Anonymous said:
Your looking at past performance and not potential value. "Entities", like Chris Begley's, friend, Mitt Romney's Bain Capital, look at value or in this case hidden value within Hospira. Bain or KKR (Private Equity) would look at the potential future value of Hospira's: 1. injectable business and it's impact on the supply of that product (HSP may have future pricing leverage), 2. oncology franchise/manufacturing, reason for acquiring Mayne Pharma (oncology mfg), 3. cash/cash flow, HSP has a great cash position from retaining earnings and not retiring debt. Debt is no problem too many large Rx companies. 4. Pharma Diversity, many properitary manufacturers don't have good drug pipelines, they look to the JNJ model for diversification. Miles White traded out HSP for Humira....going from a complex franchise of over 2,500 products made "worldwide" to one pill with enormous potential years ago. While, unloading an enormous obligation called retiree healthcare and pension within Abbott HPD. Now the pendelum will swing back. As another post noted, Abbott still has first rights to re-acquire HSP.
The question is...was that done legally?
Big Pharma/Bio-tech or Private Equity will make a move once that question is answered. Sell off the device business and streamline within a new structure.

New Capitalism of making money without a new "widget".
Click to expand...




The good ole boys are giving us the old BOHICA...Bend Over Here It Comes Again...right up the old poop shoot! I'd love to see the day one of these...or any other CEO, CFO, etc. actually EARNED their money.
 
























Top Bottom
Back
Quote